Skip to main content
Premium Trial:

Request an Annual Quote

Willim Stemmer, Nina Siegler, Alexander Bondar


Willim Stemmer has joined the scientific advisory board of Copenhagen, Denmark-based Nuevolution. Stemmer is the founder of Maygen, Avidia, and Genetic Designs, and previously worked at Affymax Research Institute, as well as Hybritech. Stemmer holds a PhD from the University of Wisconsin-Madison.

Nina Siegler was named managing director of life sciences for the Bethesda, Md.-based investment bank, National Capital. Siegler was an equities analyst for such companies as Paine Webber and Prudential Bache and also worked at the National Institutes of Health and the office of technology transfer at Johns Hopkins University. She holds an MBA from the University of Virginia, and a BS in biology from the University of North Carolina.

Alexander Bondar was named executive director for biotechnology business development for Jupiter, Fla.–based Dyadic, an industrial enzyme maker that now offers gene and protein research services. Bondar previously was employed in the life sciences group of the Aurora Funds, a Research Triangle Park, NC-based venture capital firm. He holds an MBA from Duke University.


The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.